Natural antibodies of newborns recognize oxidative stress-related malondialdehyde acetaldehyde adducts on apoptotic cells and atherosclerotic plaques

International Immunology

Volumn 25, Issue 10, 2013, Pages 575-587

  Wang, Chunguang ^a,b   Pauliina Turunen, S ^a,b   Kummu, Outi ^a,b   Veneskoski, Marja ^a,b   Lehtimäki, Jaakko ^a   Nissinen, Antti E ^b,c   Hörkkö, Sohvi ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

Innate immunity; Oxidized low density lipoprotein; Phage display; Reactive aldehydes

Indexed keywords

ACETALDEHYDE; ANTIBODY; EPITOPE; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN M; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN BINDING; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; ENDOTHELIUM CELL; GENE SEQUENCE; GERMLINE MICRONUCLEUS; HUMAN; LYMPHOCYTE; MACROPHAGE; MOUSE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PHAGE DISPLAY; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; UMBILICAL CORD BLOOD;

INNATE IMMUNITY; OXIDIZED LOW-DENSITY LIPOPROTEIN; PHAGE DISPLAY; REACTIVE ALDEHYDES;

ACETALDEHYDE; APOPTOSIS; FEMALE; FETAL BLOOD; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN M; INFANT, NEWBORN; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PEPTIDE LIBRARY; PHAGOCYTOSIS; PLAQUE, ATHEROSCLEROTIC; POLYMERS; PREGNANCY; PROTEIN ENGINEERING; SWEDEN;

EID: 84884706001     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxt022     Document Type: Article

References (53)

1. Grönwall, C., Vas, J. and Silverman, G. J. 2012. Protective Roles of Natural IgM Antibodies. Front. Immunol. 3:66.
2. Baumgarth, N., Tung, J. W. and Herzenberg, L. A. 2005. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin. Immunopathol. 26:347.
3. Kyaw, T., Tay, C., Krishnamurthi, S. et al. 2011. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ. Res. 109:830.
4. Griffin, D. O., Holodick, N. E., Rothstein, T. L. 2011. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-. J. Exp. Med. 208:67.
5. Kearley, M. L., Patel, A., Chien, J. and Tuma, D. J. 1999. Observation of a new nonfluorescent malondialdehyde-acetaldehyde- protein adduct by 13C NMR spectroscopy. Chem. Res. Toxicol. 12:100.
6. Tuma, D. J., Kearley, M. L., Thiele, G. M. et al. 2001. Elucidation of reaction scheme describing malondialdehyde-acetaldehydeprotein adduct formation. Chem. Res. Toxicol. 14:822.
7. Wyatt, T. A., Kharbanda, K. K., McCaskill, M. L. et al. 2012. Malondialdehyde-acetaldehyde-adducted protein inhalation causes lung injury. Alcohol 46:51.
8. Tuma, D. J. 2002. Role of malondialdehyde-acetaldehyde adducts in liver injury. Free Radic. Biol. Med. 32:303.
9. McCaskill, M. L., Kharbanda, K. K., Tuma, D. J. et al. 2011. Hybrid malondialdehyde and acetaldehyde protein adducts form in the lungs of mice exposed to alcohol and cigarette smoke. Alcohol. Clin. Exp. Res. 35:1106.
10. Thiele, G. M., Tuma, D. J., Willis, M. S. et al. 1998. Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant. Alcohol. Clin. Exp. Res. 22:1731.
11. Thiele, G. M., Duryee, M. J., Willis, M. S. et al. 2004. Malondialdehyde-acetaldehyde (MAA) modified proteins induce pro-inflammatory and pro-fibrotic responses by liver endothelial cells. Comp. Hepatol. 3(Suppl. 1):S25.
12. Duryee, M. J., Klassen, L. W., Schaffert, C. S. et al. 2010. Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis. Free Radic. Biol. Med. 49:1480.
13. Palinski, W., Hörkkö, S., Miller, E. et al. 1996. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J. Clin. Invest. 98:800.
14. Hill, G. E., Miller, J. A., Baxter, B. T. et al. 1998. Association of malondialdehyde-acetaldehyde (MAA) adducted proteins with atherosclerotic-induced vascular inflammatory injury. Atherosclerosis 141:107.
15. Binder, C. J. 2010. Natural IgM antibodies against oxidation-specific epitopes. J. Clin. Immunol. 30(Suppl. 1):S56.
16. Miller, Y. I., Choi, S. H., Wiesner, P. et al. 2011. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ. Res. 108:235.
17. Chou, M. Y., Fogelstrand, L., Hartvigsen, K. et al. 2009. Oxidationspecific epitopes are dominant targets of innate natural antibodies in mice and humans. J. Clin. Invest. 119:1335.
18. Friedewald, W. T., Levy, R. I. and Fredrickson, D. S. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:499.
19. Havel, R. J., Eder, H. A. and Bragdon, J. H. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34:1345.
20. Veneskoski, M., Turunen, S. P., Kummu, O. et al. 2011. Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a. Free Radic. Biol. Med. 51:834.
21. Palinski, W., Ylä-Herttuala, S., Rosenfeld, M. E. et al. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis 10:325.
22. Andris-Widhopf, J., Steinberger, P., Fuller, R., Rader, C. and Barbas, C. F., III 2001. Generation of human Fab antibody libraries: PCR amplification and assembly of light- and heavy-chain coding sequences. In Barbas, C. F., III, Burton, D. R., Scott, J. K. and Silverman, G. J., eds, Phage Display: A Laboratory Manual, 1st edn, p. 9.1-9.113. Cold Spring Harbor Laboratory Press, New York, NY.
23. Brochet, X., Lefranc, M. P. and Giudicelli, V. 2008. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36:W503.
24. Giudicelli, V., Brochet, X. and Lefranc, M. P. 2011. IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences. Cold Spring Harb. Protoc. 2011:695.
25. Turunen, S. P., Kummu, O., Harila, K. et al. 2012. Recognition of Porphyromonas gingivalis gingipain epitopes by natural IgM binding to malondialdehyde modified low-density lipoprotein. PLoS One 7:e34910.
26. Edgell, C. J., Haizlip, J. E., Bagnell, C. R. et al. 1990. Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926. In Vitro Cell. Dev. Biol. 26:1167.
27. Tuma, D. J., Thiele, G. M., Xu, D., Klassen, L. W. and Sorrell, M. F. 1996. Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology 23:872.
28. Rolla, R., Vay, D., Mottaran, E. et al. 2000. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease. Hepatology 31:878.
29. Chang, M. K., Bergmark, C., Laurila, A. et al. 1999. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. U. S. A. 96:6353.
30. Mostov, K. E. 1994. Transepithelial transport of immunoglobulins. Annu. Rev. Immunol. 12:63.
31. Simister, N. E. 2003. Placental transport of immunoglobulin G. Vaccine 21:3365.
32. Chang, M. K., Binder, C. J., Miller, Y. I. et al. 2004. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J. Exp. Med. 200:1359.
33. Greenberg, M. E., Sun, M., Zhang, R., Febbraio, M., Silverstein, R. and Hazen, S. L. 2006. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J. Exp. Med. 203:2613.
34. Ogden, C. A., Kowalewski, R., Peng, Y., Montenegro, V. and Elkon, K. B. 2005. IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo. Autoimmunity 38:259.
35. Quartier, P., Potter, P. K., Ehrenstein, M. R., Walport, M. J. and Botto, M. 2005. Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur. J. Immunol. 35:252.
36. Chen, Y., Khanna, S., Goodyear, C. S. et al. 2009. Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J. Immunol. 183:1346.
37. Chen, Y., Park, Y. B., Patel, E. and Silverman, G. J. 2009. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J. Immunol. 182:6031.
38. Notley, C. A., Brown, M. A., Wright, G. P. and Ehrenstein, M. R. 2011. Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J. Immunol. 186:4967.
39. Boes, M., Schmidt, T., Linkemann, K., Beaudette, B. C., Marshak-Rothstein, A. and Chen, J. 2000. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. U. S. A. 97:1184.
40. Kaveri, S. V., Silverman, G. J. and Bayry, J. 2012. Natural IgM in immune equilibrium and harnessing their therapeutic potential. J. Immunol. 188:939.
41. Yamashita, T., Freigang, S., Eberle, C. et al. 2006. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring. Circ. Res. 99:e51.
42. Eberle, C., Merki, E., Yamashita, T. et al. 2012. Maternal immunization affects in utero programming of insulin resistance and type 2 diabetes. PLoS One 7:e45361.
43. Roy, A., Bauer, S. M. and Lawrence, B. P. 2012. Developmental exposure to bisphenol A modulates innate but not adaptive immune responses to influenza A virus infection. PLoS One 7:e38448.
44. Malhotra, I., Dent, A., Mungai, P. et al. 2009. Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya. PLoS Med. 6:e1000116.
45. Grindstaff, J. L., Hasselquist, D., Nilsson, J. K., Sandell, M., Smith, H. G. and Stjernman, M. 2006. Transgenerational priming of immunity: maternal exposure to a bacterial antigen enhances offspring humoral immunity. Proc. Biol. Sci. 273:2551.
46. Babik, J. M., Cohan, D., Monto, A., Hartigan-O'Connor, D. J. and McCune, J. M. 2011. The human fetal immune response to hepatitis C virus exposure in utero. J. Infect. Dis. 203:196.
47. Napoli, C., D'Armiento, F. P., Mancini, F. P. et al. 1997. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J. Clin. Invest. 100:2680.
48. Liguori, A., D'Armiento, F. P., Palagiano, A. et al. 2007. Effect of gestational hypercholesterolaemia on omental vasoreactivity, placental enzyme activity and transplacental passage of normal and oxidised fatty acids. BJOG. 114:1547.
49. Merbl, Y., Zucker-Toledano, M., Quintana, F. J. and Cohen, I. R. 2007. Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J. Clin. Invest. 117:712.
50. Weismann, D., Hartvigsen, K., Lauer, N. et al. 2011. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478:76.
51. Speidl, W. S., Kastl, S. P., Huber, K. and Wojta, J. 2011. Complement in atherosclerosis: friend or foe? J. Thromb. Haemost. 9:428.
52. Oksjoki, R., Laine, P., Helske, S. et al. 2007. Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques. Atherosclerosis 195:90.
53. Willis, M. S., Thiele, G. M., Tuma, D. J. and Klassen, L. W. 2003. T cell proliferative responses to malondialdehyde-acetaldehyde haptenated protein are scavenger receptor mediated. Int. Immunopharmacol. 3:1381.